SCHEMBL26324862

SCHEMBL26324862

CC(C)OC(=O)C(C(C)C)N(CCO[Si](C)(C)C(C)(C)C)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTN3A1 O00481 4/20 0.39
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
KMT2A Q03164 4/20 0.33
MEN1 O00255 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TSHR P16473 1/20 0.33
CHRM2 P08172 2/20 0.32
CHRM1 P11229 2/20 0.32
CHRM3 P20309 2/20 0.32
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
DGAT1 O75907 1/20 0.31
GAA P10253 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20565216 0.88 BTN3A1 (0.40) BTN3A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL26324890 0.77 ALDH1A1 (0.39) KMT2AMEN1SMN1; SMN2CYP3A4CYP2C9
SCHEMBL26324920 0.77 TSHR (0.44) CHRNB2CHRNB4CHRNA3CHRNA4KMT2A
SCHEMBL26324865 0.74 TSHR (0.38) BTN3A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL26324941 0.74 TSHR (0.46) CHRNB2CHRNB4CHRNA3CHRNA4KMT2A
SCHEMBL14852043 0.71 SMN1; SMN2 (0.43) KMT2AMEN1SMN1; SMN2CYP3A4CYP2C9
SCHEMBL26324800 0.70 TSHR (0.42) CHRNB2CHRNB4CHRNA3CHRNA4KMT2A
SCHEMBL3342299 0.70 MEN1 (0.39) KMT2AMEN1SMN1; SMN2CYP3A4CYP2C9
SCHEMBL26324873 0.69 TSHR (0.41) CHRNB2CHRNB4CHRNA3CHRNA4KMT2A
SCHEMBL14851873 0.69 RAB9A (0.52) KMT2AMEN1SMN1; SMN2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 BTN3A1 1491/4885CHRNB2 1465/4885CHRNB4 1958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.